Filter posts

8 Biggest Debates in American Food Policy

It turns out that figuring out how we should grow, sell, and tax our food …

BIO Participating in IDSA Stakeholder Group on Antimicrobial Resistance

BIO will be participating in a newly formed partnership which will work collaboratively to inform …

New CDC Tool to Track Antibiotic Use & Resistance

Antibiotic resistance is quickly becoming one of the most serious threats facing our health care …

Precision Drugs for Bad Bugs

Awareness is high that antibiotic resistance is a critical problem, but many still don’t appreciate …

BIO CEO Company Snapshot: Tetraphase Pharmaceuticals

The BIO CEO & Investor Conference is now just a week away, and buzz for …

New CDC Report on Alarming Rates of Antibiotic-Resistant Infections

Every year in the United States, 2 million people acquire an antibiotic-resistant infection. Of those, at …

#BIF2012 Company Snapshot: ContraFect Corporation

The BIO Investor Forum is fast approaching! Below you’ll find our first Company Snapshot of …

Resistance is Futile – SuperDrugs for SuperBugs

“MRSA’s kill 100,000 people a year, more than AIDS,” said Mark Leuchetenberger, President and CEO, …

BIO submits comments on Australian Senate Patent Amendment

The Australian Senate has proposed the Patent Amendment (Human Genes and Biological Materials) Bill 2010 that …